126 related articles for article (PubMed ID: 2839829)
1. Molecular and biological interaction between major histocompatibility complex class I antigens and luteinizing hormone receptors or beta-adrenergic receptors triggers cellular response in mice.
Solano AR; Cremaschi G; Sánchez ML; Borda E; Sterin-Borda L; Podestá EJ
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5087-91. PubMed ID: 2839829
[TBL] [Abstract][Full Text] [Related]
2. Luteinizing hormone triggers a molecular association between its receptor and the major histocompatibility complex class I antigen to produce cell activation.
Solano AR; Sanchez ML; Sardanons ML; Dada L; Podestá EJ
Endocrinology; 1988 May; 122(5):2080-3. PubMed ID: 3359976
[TBL] [Abstract][Full Text] [Related]
3. Rotational dynamics of luteinizing hormone receptors and MHC class I antigens on murine Leydig cells.
Philpott CJ; Rahman NA; Kenny N; Londo TR; Young RM; Barisas BG; Roess DA
Biochim Biophys Acta; 1995 Apr; 1235(1):62-8. PubMed ID: 7718609
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of complimentarity between monoclonal antibodies (MAbs) to human chorionic gonadotropin (hCG) and polyclonal antibodies to luteinizing hormone/hCG receptor (LH-R) and their use in better understanding hormone-receptor interaction.
Jeyakumar M; Krishnamurthy HN; Dighe RR; Moudgal NR
Recept Signal Transduct; 1997; 7(4):299-310. PubMed ID: 9633830
[TBL] [Abstract][Full Text] [Related]
5. Immunization of male rabbits with sheep luteal receptor to LH results in production of antibodies exhibiting hormone-agonistic and -antagonistic activities.
Jeyakumar M; Moudgal NR
J Endocrinol; 1996 Sep; 150(3):431-43. PubMed ID: 8882162
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic effects on mouse isolated atria of immunoglobulins directed against class I histocompatibility antigens.
Cremaschi GA; Sterin-Borda L; Genaro AM; Borda ES; Braun M
J Immunol; 1984 Nov; 133(5):2681-5. PubMed ID: 6481168
[TBL] [Abstract][Full Text] [Related]
7. Alloimmune IgG binds and modulates cardiac beta-adrenoceptor activity.
Sterin-Borda L; Cremaschi G; Pascual J; Genaro A; Borda E
Clin Exp Immunol; 1984 Oct; 58(1):223-8. PubMed ID: 6090043
[TBL] [Abstract][Full Text] [Related]
8. Luteinizing hormone receptors and testosterone production in whole testes and purified Leydig cells from the mouse: differences among inbred strains.
Stalvey JR; Payne AH
Endocrinology; 1983 May; 112(5):1696-701. PubMed ID: 6299705
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility complex modulation of beta-adrenoceptor function.
Cremaschi G; Borda E; Sales M; Genaro A; Sterin-Borda L
Biochem Pharmacol; 1990 Jun; 39(12):1861-8. PubMed ID: 2162169
[TBL] [Abstract][Full Text] [Related]
10. Does gonadotropin receptor complex have an amplifying role in cAMP/testosterone production in Leydig cells?
Browne ES; Bhalla VK
J Androl; 1991; 12(2):132-9. PubMed ID: 1646778
[TBL] [Abstract][Full Text] [Related]
11. Allopregnant IgG binds and modulates the activity of uterine beta adrenoceptors.
Sales ME; Borda E
Acta Physiol Pharmacol Ther Latinoam; 1993; 43(1-2):45-52. PubMed ID: 7865874
[TBL] [Abstract][Full Text] [Related]
12. Evidence for interactions between HLA system class I and beta-adrenergic receptors in human mononuclear leukocytes.
Pende A; Ioverno A; Setti M; Bosco O; Musso NR; Vergassola C; Lanza L; Indiveri F; Lotti G
J Clin Endocrinol Metab; 1993 Nov; 77(5):1329-33. PubMed ID: 8077328
[TBL] [Abstract][Full Text] [Related]
13. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
Dirami G; Cooke BA
Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
[TBL] [Abstract][Full Text] [Related]
14. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
Navickis RJ; Shimkin MB; Hsueh AJ
Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
[TBL] [Abstract][Full Text] [Related]
15. Continuous and pulsatile infusions of luteinizing hormone have identical effects on steroidogenic capacity and sensitivity of Leydig cells in rats passively immunized against gonadotropin-releasing hormone.
Gibson-Berry KL; Chase DJ
Endocrinology; 1990 Jun; 126(6):3107-15. PubMed ID: 1693567
[TBL] [Abstract][Full Text] [Related]
16. Immunization against exon 1 decapeptides from the lutropin/choriogonadotropin receptor or the follitropin receptor as potential male contraceptive.
Remy JJ; Couture L; Rabesona H; Haertle T; Salesse R
J Reprod Immunol; 1996 Nov; 32(1):37-54. PubMed ID: 8953519
[TBL] [Abstract][Full Text] [Related]
17. Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum.
Moncayo H; Moncayo R; Benz R; Wolf A; Lauritzen C
J Clin Invest; 1989 Dec; 84(6):1857-65. PubMed ID: 2592563
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the truncation of luteinizing hormone receptors at the plasma membrane is different in rat and mouse Leydig cells.
West AP; Cooke BA
Endocrinology; 1991 Jan; 128(1):363-70. PubMed ID: 1846104
[TBL] [Abstract][Full Text] [Related]
19. Effects of 6-hydroxydopamine on testosterone production by mouse leydig cells in vitro.
Wango EO; Odongo HO; Oduma J; Oduor-Okelo D
Acta Biol Hung; 1995; 46(1):75-85. PubMed ID: 8714765
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces.
Coutinho A; Augustin AA
Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
